Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Scientific Reports|February 26, 2020
A universal reporter cell line for bioactivity evaluation of engineered cytokine productsJacqueline Mock, Christian Pellegrino, Dario Neri
Archivos Argentinos De Pediatria|July 5, 2012
[Newborn with lung mass of uncommon etiology]Christian Pellegrino Cid, Silvana Maglio, Luis Fernando Gentile
Journal of Medicinal Chemistry|October 28, 2021
Specific Inhibitor of Placental Alkaline Phosphatase Isolated from a DNA-Encoded Chemical Library Targets Tumor of the Female Reproductive TractGabriele Bassi, Nicholas Favalli, Christian Pellegrino, et al.
Molecular Cancer Therapeutics|March 4, 2025
PSMA-targeted Small Molecule-Drug Conjugates based on a Post-Prolyl Peptidase Cleavable Linker for the Treatment of Prostate CancerTony Georgiev, Sara Puglioli, Lucrezia Principi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 2, 2022
Cross-reactivity to glutamate carboxypeptidase III causes undesired salivary gland and kidney uptake of PSMA-targeted small-molecule radionuclide therapeuticsLaura Lucaroni, Tony Georgiev, Eleonora Prodi, et al.
Bioconjugate Chemistry|June 10, 2020
Impact of Ligand Size and Conjugation Chemistry on the Performance of Universal Chimeric Antigen Receptor T-Cells for Tumor KillingChristian Pellegrino, Nicholas Favalli, Michael Sandholzer, et al.
Molecular Cancer Therapeutics|September 30, 2025
Immunocompetent mouse models of cancer reveal the superiority of cellular targets over stromal targets for the development of anticancer bispecific antibodiesStefanie K Pfister, Frauke Seehusen, Francesco Prisco, et al.
Molecular Cancer Therapeutics|March 17, 2026
A bispecific anti-fluorescein x anti-CD3 T-cell engager in combination with fluoresceinated adaptors enables lysis of AML cellsLaura G Volta, Celeste Gobbi, Christian Koch, et al.
Molecular Cancer Therapeutics|May 11, 2026
A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML CellsLaura G Volta, Celeste Gobbi, Christian Koch, et al.
Oncoimmunology|October 8, 2024
Peptide-guided adaptor-CAR T-Cell therapy for the treatment of SSTR2-expressing neuroendocrine tumorsChristian Pellegrino, Nicholas Favalli, Laura Volta, et al.
Pageof 3